long term side effects of glp-1 receptor agonists Long-Term GLP-1s: Risks & Benefits – Forbes Health GLP-1 Receptor Agonists | New

Castelluccio C, Paganga G, Melikian N, Bolwell GP, Pridham J, Sampson J, et al

Maekawa, S

and Gonzlez, N

10.1074/jbc.M200755200 J

Eser TM, Baranov O, Huth M, Ahmed M, Dek F, Held K, et al

Why women need lower doses Biological differences: Smaller average body size Different hormone profiles More sensitive to some peptides Better response at lower doses often General rule: Start 20-30% lower than male doses Women: 150-200mcg vs Men: 200-300mcg (GH peptides) Titrate based on response More isn't better for women Hormone cycle considerations (perimenopause) If still menstruating: GH peptides: Use consistently throughout cycle Weight loss peptides: May work better in follicular phase (days 1-14) Some women dose higher during luteal phase (more resistant) Track response across full cycle Post-menopause: No cycle to consider Consistent dosing easier More predictable results Age-specific dosing Women 40-50 (perimenopause): Start conservative Body still producing some hormones Lower doses effective Women 50-60 (menopause): Standard doses appropriate Need more GH replacement Can titrate higher if needed Women 60-70+: Start very low Increase slowly More sensitive to side effects Benefits still significant Safety considerations for women over 40 Special precautions for this demographic